Antibodies to elastin peptides in sera of Warmblood horses at different ages

L. Van Brantegem, H. E V De Cock, Verena K Affolter, L. Duchateau, J. Govaere, G. L. Ferraro, R. Ducatelle

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Reasons for performing study: Early diagnosis and monitoring progression of chronic diseases in elastin-rich tissues, such as chronic progressive lymphoedema in draught horses and chronic obstructive pulmonary disease (COPD) is still a real challenge in the horse. Use of an enzyme-linked immunosorbent assay (ELISA) to detect anti-elastin antibody (AEAb) levels might be useful to assess the status of such diseases. Baseline levels, representing physiological breakdown of elastin in normal horses, are not available at present. Hypothesis: Levels of AEAb in healthy horses are generally low and follow the same age-related pattern as found in man. Therefore, elevation of AEAb levels in serum can be used to evaluate pathological elastin breakdown in elastin-rich tissues. Methods: Sera of 84 clinically healthy Warmblood horses were evaluated for the presence of AEAbs by means of a modified version of an ELISA technique used in man. The horses were divided in 5 age groups: A) <4 months; B) 4-23 months; C) 2-3 years; D) 4-10 years; and E) >11 years. Results: Antibodies to elastin were found in all equine serum samples tested. Their levels were lowest in Group A, low in Groups B and E and highest in animals age 2-10 years. Conclusions: Measuring AEAbs in serum of horses by an ELISA technique proved to be possible and levels were stable during well-defined life stages. Potential relevance: Changes in AEAb levels are expected to be useful for early diagnosis and for monitoring progression of diseases that affect elastin-rich tissues, such as chronic progressive lymphoedema and COPD.

Original languageEnglish (US)
Pages (from-to)414-416
Number of pages3
JournalEquine Veterinary Journal
Volume39
Issue number5
DOIs
StatePublished - Sep 2007

Fingerprint

elastin
Elastin
Horses
peptides
horses
Peptides
antibodies
Antibodies
Serum
Anti-Idiotypic Antibodies
Immunosorbent Techniques
Lymphedema
early diagnosis
Enzyme-Linked Immunosorbent Assay
enzyme-linked immunosorbent assay
respiratory tract diseases
Chronic Obstructive Pulmonary Disease
Early Diagnosis
monitoring
animal age

Keywords

  • Anti-elastin antibodies
  • Elastin
  • ELISA
  • Horse

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Van Brantegem, L., De Cock, H. E. V., Affolter, V. K., Duchateau, L., Govaere, J., Ferraro, G. L., & Ducatelle, R. (2007). Antibodies to elastin peptides in sera of Warmblood horses at different ages. Equine Veterinary Journal, 39(5), 414-416. https://doi.org/10.2746/042516407X204573

Antibodies to elastin peptides in sera of Warmblood horses at different ages. / Van Brantegem, L.; De Cock, H. E V; Affolter, Verena K; Duchateau, L.; Govaere, J.; Ferraro, G. L.; Ducatelle, R.

In: Equine Veterinary Journal, Vol. 39, No. 5, 09.2007, p. 414-416.

Research output: Contribution to journalArticle

Van Brantegem, L, De Cock, HEV, Affolter, VK, Duchateau, L, Govaere, J, Ferraro, GL & Ducatelle, R 2007, 'Antibodies to elastin peptides in sera of Warmblood horses at different ages', Equine Veterinary Journal, vol. 39, no. 5, pp. 414-416. https://doi.org/10.2746/042516407X204573
Van Brantegem, L. ; De Cock, H. E V ; Affolter, Verena K ; Duchateau, L. ; Govaere, J. ; Ferraro, G. L. ; Ducatelle, R. / Antibodies to elastin peptides in sera of Warmblood horses at different ages. In: Equine Veterinary Journal. 2007 ; Vol. 39, No. 5. pp. 414-416.
@article{75d011b9a6f84fa4858602fadc277366,
title = "Antibodies to elastin peptides in sera of Warmblood horses at different ages",
abstract = "Reasons for performing study: Early diagnosis and monitoring progression of chronic diseases in elastin-rich tissues, such as chronic progressive lymphoedema in draught horses and chronic obstructive pulmonary disease (COPD) is still a real challenge in the horse. Use of an enzyme-linked immunosorbent assay (ELISA) to detect anti-elastin antibody (AEAb) levels might be useful to assess the status of such diseases. Baseline levels, representing physiological breakdown of elastin in normal horses, are not available at present. Hypothesis: Levels of AEAb in healthy horses are generally low and follow the same age-related pattern as found in man. Therefore, elevation of AEAb levels in serum can be used to evaluate pathological elastin breakdown in elastin-rich tissues. Methods: Sera of 84 clinically healthy Warmblood horses were evaluated for the presence of AEAbs by means of a modified version of an ELISA technique used in man. The horses were divided in 5 age groups: A) <4 months; B) 4-23 months; C) 2-3 years; D) 4-10 years; and E) >11 years. Results: Antibodies to elastin were found in all equine serum samples tested. Their levels were lowest in Group A, low in Groups B and E and highest in animals age 2-10 years. Conclusions: Measuring AEAbs in serum of horses by an ELISA technique proved to be possible and levels were stable during well-defined life stages. Potential relevance: Changes in AEAb levels are expected to be useful for early diagnosis and for monitoring progression of diseases that affect elastin-rich tissues, such as chronic progressive lymphoedema and COPD.",
keywords = "Anti-elastin antibodies, Elastin, ELISA, Horse",
author = "{Van Brantegem}, L. and {De Cock}, {H. E V} and Affolter, {Verena K} and L. Duchateau and J. Govaere and Ferraro, {G. L.} and R. Ducatelle",
year = "2007",
month = "9",
doi = "10.2746/042516407X204573",
language = "English (US)",
volume = "39",
pages = "414--416",
journal = "Equine veterinary journal. Supplement",
issn = "2042-3306",
publisher = "British Equine Veterinary Association",
number = "5",

}

TY - JOUR

T1 - Antibodies to elastin peptides in sera of Warmblood horses at different ages

AU - Van Brantegem, L.

AU - De Cock, H. E V

AU - Affolter, Verena K

AU - Duchateau, L.

AU - Govaere, J.

AU - Ferraro, G. L.

AU - Ducatelle, R.

PY - 2007/9

Y1 - 2007/9

N2 - Reasons for performing study: Early diagnosis and monitoring progression of chronic diseases in elastin-rich tissues, such as chronic progressive lymphoedema in draught horses and chronic obstructive pulmonary disease (COPD) is still a real challenge in the horse. Use of an enzyme-linked immunosorbent assay (ELISA) to detect anti-elastin antibody (AEAb) levels might be useful to assess the status of such diseases. Baseline levels, representing physiological breakdown of elastin in normal horses, are not available at present. Hypothesis: Levels of AEAb in healthy horses are generally low and follow the same age-related pattern as found in man. Therefore, elevation of AEAb levels in serum can be used to evaluate pathological elastin breakdown in elastin-rich tissues. Methods: Sera of 84 clinically healthy Warmblood horses were evaluated for the presence of AEAbs by means of a modified version of an ELISA technique used in man. The horses were divided in 5 age groups: A) <4 months; B) 4-23 months; C) 2-3 years; D) 4-10 years; and E) >11 years. Results: Antibodies to elastin were found in all equine serum samples tested. Their levels were lowest in Group A, low in Groups B and E and highest in animals age 2-10 years. Conclusions: Measuring AEAbs in serum of horses by an ELISA technique proved to be possible and levels were stable during well-defined life stages. Potential relevance: Changes in AEAb levels are expected to be useful for early diagnosis and for monitoring progression of diseases that affect elastin-rich tissues, such as chronic progressive lymphoedema and COPD.

AB - Reasons for performing study: Early diagnosis and monitoring progression of chronic diseases in elastin-rich tissues, such as chronic progressive lymphoedema in draught horses and chronic obstructive pulmonary disease (COPD) is still a real challenge in the horse. Use of an enzyme-linked immunosorbent assay (ELISA) to detect anti-elastin antibody (AEAb) levels might be useful to assess the status of such diseases. Baseline levels, representing physiological breakdown of elastin in normal horses, are not available at present. Hypothesis: Levels of AEAb in healthy horses are generally low and follow the same age-related pattern as found in man. Therefore, elevation of AEAb levels in serum can be used to evaluate pathological elastin breakdown in elastin-rich tissues. Methods: Sera of 84 clinically healthy Warmblood horses were evaluated for the presence of AEAbs by means of a modified version of an ELISA technique used in man. The horses were divided in 5 age groups: A) <4 months; B) 4-23 months; C) 2-3 years; D) 4-10 years; and E) >11 years. Results: Antibodies to elastin were found in all equine serum samples tested. Their levels were lowest in Group A, low in Groups B and E and highest in animals age 2-10 years. Conclusions: Measuring AEAbs in serum of horses by an ELISA technique proved to be possible and levels were stable during well-defined life stages. Potential relevance: Changes in AEAb levels are expected to be useful for early diagnosis and for monitoring progression of diseases that affect elastin-rich tissues, such as chronic progressive lymphoedema and COPD.

KW - Anti-elastin antibodies

KW - Elastin

KW - ELISA

KW - Horse

UR - http://www.scopus.com/inward/record.url?scp=38449120182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449120182&partnerID=8YFLogxK

U2 - 10.2746/042516407X204573

DO - 10.2746/042516407X204573

M3 - Article

C2 - 17910265

AN - SCOPUS:38449120182

VL - 39

SP - 414

EP - 416

JO - Equine veterinary journal. Supplement

JF - Equine veterinary journal. Supplement

SN - 2042-3306

IS - 5

ER -